Loading...
The utilization of esophagogastric duodenoscopy (EGD) in patients with gastroesophageal reflux disease (GERD) has increased dramatically during the last decade. Much of this increase is attributable to the use of EGD as a screening test for Barrett esophagus (BE), which is a precancerous condition. However, recent studies suggest that endoscopic surveillance for BE is overutilized (JW Gastroenterol Mar 30 2012) and that the incidence of progression from BE to esophageal adenocarcinoma has been overestimated (JW Gastroenterol Aug 19 2011).
Within this context, the American College of Physicians has released best practice advice to clinicians on appropriate referral indications for EGD in patients with GERD:
Heartburn and “alarm symptoms” (dysp…